top of page
Fleet's premises in Hampshire UK

Dr David Corser

Operations Director

Holds a PhD in Organic Chemistry, performed a post-doctoral project on antibody-directed drug delivery systems, and was formerly a senior scientist with Ortho-Clinical Diagnostics. He has 25 years of experience in the development and validation of bioconjugation methods, and has a particular interest in selective thiol reduction of monoclonal antibodies.


Protection against experimental melioidosis following immunisation with a lipopolysaccharide-protein conjugate. Scott AE, Ngugi SA, Laws TR, Corser D, Lonsdale CL, D'Elia RV, Titball RW, Williamson ED, Atkins TP, Prior JL. J Immunol Res. 2014

Company Management

bottom of page